Identifiers
HUGO:KIR2DL4
Maps_Modules
HMC:AVOIDING_IMMUNE_DESTRUCTION
Innate Immunity / MARKERS_NK
References
CASCADE:KIR2DL4
CASCADE:IL2
NATURAL_KILLER
PMID:11994457, PMID:11513144, PMID:16287995, PMID:12055234
KIR2DL4 (CD158d) is an NK cell-activating receptor with inhibitory potential.
KIR2DL4 (CD158d) is a receptor for the nonclassical HLA-G.
HLA-G is normally expressed only on fetal-derived trophoblast cells that invade the maternal decidua in pregnant women.
But it is expressed by many tumor cells and probably provides tumor escape from NK killing.
PMID:11994457
Tyrosine-phosphorylated KIR2DL4 inhibits NK cytotoxixity. It inhibits the immunoreceptor tyrosine-based activation motif (ITAM)-dependent activation mediated by NKp46 or the ITAM-independent activation mediated by 2B4.
via binding and activation of SHP-2
PMID:9751747
KIR2DL3, KIR2DL1, KIR2DS4, KIR3DL1, KIR3DL2, KIR2DL4 interact with SHP-2 in NK cells
and probably are phosphorylated by LCK 5directly demonstrated for KIR2DL3 only.
(CL6 = KIR2DL3,CL42 =KIR2DL1, CL39 = KIR2DS4, NKAT3= KIR3DL1, NKAT4 = KIR3DL2,KIR103AS=KIR2DL4).
PMID:11489965, PMID:15778339
???KIR2DL4 transduces signals into human NK cells through association with the Fc receptor gamma protein. It induces IFNG production via p38 but not cytotoxicity in resting NK cells.
PMID:15778339
IL2 stimulates surface expression of KIR2DL4 (2DL4.1)and NKp46
PMID:17100877
KIR2DL4 both contains a cytoplasmic ITIM and encodes a transmembrane arginine residue, through which it can associate with the Fc??R??-chain
KIR2DL4 transduces signals into human NK cells through association with the Fc receptor gamma protein. It induces IFNG production but not cytotoxicity in resting NK cells